India allows limited exports of anti-malaria drug after Donald Trump warns of retaliation
By Neha Dasgupta, Sanjeev Miglani NEW DELHI: India, the world’s main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus. The Indian government had put a hold on exports of […]